©2019 by Enlighta Inc.

INTERVENTION

Major developments and partnerships are pending and will be announced via news release shortly - at which time we will update this webpage accordingly.

Once the medical diagnostic test, AI and physician review has confirmed a disease indication, Enlighta will work with their partners to provide world class medical intervention and treatments.  Interventions include leading immunotherapy, stem cell therapy, NK cell therapy, radiation / laser therapy, anti-aging treatments, targeted pharmaceutical/chemotherpy formulations, etc.

Analyzing Scans
 

PREMIER CLINICAL PARTNER

Meinian Onehealth Healthcare (Group) Co., Ltd

http://www.health-100.cn/

Founded in 2004, Meinian / Health 100 is a professional health checkup and medical service group headquartered in Shanghai, China.  Meinian officially completed the full coverage of China's territory in 2018 (except Hong Kong, Macao and Taiwan) with more than 600 professional medical examination centres in the country.  The entire Meinian group has more than 70,000 employees, including experts, medical staff and management personnel.  In 2018, it provided professional health services for nearly 30 million people, and is expected to exceed 100 million in 2021.  Meinian successfully listed its A shares on the Shenzhen Stock Exchange in August 2015 (SZ: 002044).  As at July 26 2019, Meinian had a market capitalization of 36.8 Billion RMB